Adaptimmune Therapeutics PLC (ADAP)
0.7682
-0.03
(-3.21%)
USD |
NASDAQ |
Nov 13, 16:00
0.84
+0.07
(+9.35%)
After-Hours: 20:00
Adaptimmune Therapeutics Income from Continuing Operations (Quarterly)
Income from Continuing Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Income from Continuing Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -- |
| March 31, 2024 | -- |
| December 31, 2023 | -- |
| September 30, 2023 | -- |
| June 30, 2023 | -- |
| March 31, 2023 | -- |
| December 31, 2022 | -- |
| September 30, 2022 | -- |
| June 30, 2022 | -- |
| March 31, 2022 | -- |
| December 31, 2021 | -- |
| September 30, 2021 | -- |
| June 30, 2021 | -- |
| March 31, 2021 | -- |
| December 31, 2020 | -- |
| September 30, 2020 | -- |
| June 30, 2020 | -- |
| March 31, 2020 | -- |
| December 31, 2019 | -- |
| Date | Value |
|---|---|
| September 30, 2019 | -- |
| June 30, 2019 | -- |
| March 31, 2019 | -- |
| December 31, 2018 | -- |
| September 30, 2018 | -- |
| June 30, 2018 | -- |
| March 31, 2018 | -- |
| December 31, 2017 | -- |
| September 30, 2017 | -- |
| June 30, 2017 | -- |
| March 31, 2017 | -- |
| December 31, 2016 | -- |
| September 30, 2016 | -- |
| June 30, 2016 | -- |
| March 31, 2016 | -- |
| September 30, 2015 | -- |
| December 31, 2014 | -- |
| September 30, 2014 | -- |
Income from Continuing Operations Definition
Income Statement line item that does not account extraordinary items and discontinued operations. This metric is frequently used because it excludes items that are unlikely to happen the next reporting period.